ACCP – American College of Chest Physicians (2012a). Guideline: Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis. Chest. 141(2): Supplement: e326S–e350S.CrossRefGoogle Scholar

ACCP – American College of Chest Physicians (2012b). Guideline: Prevention of VTE in Orthopedic Surgery Patients - Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians. Chest. 141(2): Supplement: e278S–e325S.Google Scholar

Bermar, A.R. (2001). Pulmonary embolism in the elderly. Clin Geriatr Med. 17(1): 107–130.CrossRefGoogle Scholar

CEC – Clinical Exellence Commission. (2016). Non-Vitamin K Antagonists Oral Anticoagulant (NOACS) Guidelines. Sydney: Clinical Excellence Commission.Google Scholar

Dennis, M., Sandercock, P.A., Reid, J., et al. (2009). Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 373(9679): 1958–1965.Google ScholarPubMed

ESA – European Society of Anaesthesiology (2017). Guidelines on prevention of venous thromboembolism in anaesthesia and intensive care. Eur J Anaesth.Google Scholar

Heidbuchel, H., Verhamme, P., Alings, M., et al. (2016). Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Eur Heart J. Jun 9. pii: ehw058. doi: doi.org/10.1093/eurheartj/ehw058Google Scholar

Heit, J.A. (2015). Epidemiology of venous thromboembolism. Nat Rev Cardiol. 12: 464–474.CrossRefGoogle ScholarPubMed

Henke, P.K., Diaz, J.A., Meyers, D.D. Jr., Wakefield, T.W. (2012). Recent insights into the molecular and cellular contributions to venous thrombosis. In: Homeister, J.W. and Wills, M.S., Molecular and Translational Vascular Medicine. New York: Springer Science+Business Media.Google Scholar

İpek, G., Karataş, M.B., Onuk, T. et al. (2015). Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism. J Thromb Thrombolysis. 40(4): 424–429.CrossRefGoogle ScholarPubMed

Kucher, N. (2011). Clinical practice: deep-vein thrombosis of the upper extremities. N Engl J Med. 364: 861–869.CrossRefGoogle ScholarPubMed

Lindblad, B., Eriksson, A., Bergqvist, D. (1991). Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg. 78(7):849–852.Google Scholar

Lowe, G.D., Rumley, A., Woodward, M., et al. (1997). Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 97: 775–784.CrossRefGoogle ScholarPubMed

Lowe, G.D., Rumley, A., Woodward, M., et al. (1999). Activated protein C resistance and the FV:R506Q mutation in a random population sample–associations with cardiovascular risk factors and coagulation variables. Thromb Haemost. 81: 918–924.Google Scholar

Machlus, K.R., Aleman, M.M., Wolberg, A.S. (2011). Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arterioscler Thromb Vasc Biol. 31: 476–478.Google Scholar

Mahe, I., Gouin-Thibault, I., Drouet, L., et al. (2007). Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity level. Drugs Aging. 24: 63–71.Google Scholar

Masotti, L., Ray, P., Righini, M. et al. (2008). Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation. Vasc Hralth Risk Manag. 4(3): 629–636.CrossRefGoogle ScholarPubMed

Mismetti, P., Laporte, S., Darmon, J.Y., Buchmüller, A., Decousus, H. (2001). Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 88(7): 913–930.CrossRefGoogle ScholarPubMed

Naess, I.A., Christiansen, S.C., Romundstad, P., et al. (2007). Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 5: 692–699.CrossRefGoogle ScholarPubMed

NICE – National Institute for Health and Care Excellence (2012). Guidance for prescribing NOACs in patients with non-valvular AF. Available from: www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/Prescribing-Guidance-for-NOACs.pdf (last accessed March 2017).Google Scholar

Rafflenbeul, E., Müller-Ehmsen, J. (2017). Vitamin K antagonists: is their prescription really “medical malpractice” today? Internist. 58(1): 90–99.Google Scholar

Righini, M., Goehring, C., Bounameaux, H. et al. (2000). Effect of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med. 109: 357–361.Google Scholar

Samos, M., Stanciakova, L., Skornova, I., et al. (2017). Review of the pharmacology of the emerging possibilities of the direct oral anticoagulant reversal.CrossRefGoogle Scholar

Sardar, P., Chatterjee, S., Chaudhari, S., Lip, G.Y.H. (2014). New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. J Am Geriat Soc. 62: 857–864.CrossRefGoogle ScholarPubMed

Silverstein, M.D., Heit, J.A., Mohr, D.N., et al. (1998). Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 158: 585–593.Google Scholar

Silverstein, R.L., Bauer, K.A., Cushman, M., et al. (2007). Venous thrombosis in the elderly: more questions than answers. Blood. 110: 3097–3101.CrossRefGoogle ScholarPubMed

Tsai, A.W., Crushman, M., Rosamond, W.D., et al. (2002). Coagulation factors, inflammation markers and venous thromboembolism: the longitudinal investigation of the thromboembolism etiology (LITE). Am J Med. 113(8): 636–642.CrossRefGoogle ScholarPubMed